XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Aug. 31, 2017
Aug. 31, 2016
Operating activities    
Net income $ 4,226 $ 5,221
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment expense 8,545 8,467
Stock-based compensation expense 17,011 15,833
Excess tax benefits from equity compensation plans 0 (791)
Deferred income taxes 804 474
Other (261) (728)
Changes in operating assets and liabilities:    
Accounts receivable, net (318) 2,732
Inventories, net (744) (83)
Income taxes, net 8,122 3,598
Deferred costs (4,738) 340
Other assets (5,027) (597)
Accounts payable (3,043) (6,679)
Accrued payroll and related benefits (641) 1,126
Other liabilities (481) (762)
Deferred revenue 7,755 4,456
Net cash provided by operating activities 31,210 32,607
Investing activities    
Purchases of marketable securities (21,769) (21,777)
Proceeds from the sale of marketable securities 12,250 10,294
Proceeds from the maturity of marketable securities 8,342 8,018
Purchases of non-marketable investments (4,000) (636)
Purchases of property and equipment (7,816) (2,969)
Purchases of intangible assets 0 (1,000)
Business combinations, net of cash acquired (506) (243)
Payments for the sale of net liabilities (800) 0
Net cash used in investing activities (14,299) (8,313)
Financing activities    
Proceeds from issuance of common stock 3,009 4,869
Taxes paid related to net share settlement of equity awards (4,474) (2,544)
Excess tax benefits from equity compensation plans 0 791
Employee loans extended, net of repayment 31 (2)
Repayment of note payable (4,115) (133)
Repurchases of common stock (6,546) (7,241)
Payments of acquisition-related liabilities (743) 0
Net cash used in financing activities (12,838) (4,260)
Effect of exchange rate changes 1,335 463
Net increase in cash, cash equivalents and restricted cash 5,408 20,497
Cash, cash equivalents and restricted cash at beginning of period 120,837 119,333
Cash, cash equivalents and restricted cash at end of period $ 126,245 $ 139,830